A Case-Based Guide To Clinical Endocrinology
A Case-Based Guide To Clinical Endocrinology - https://urlca.com/2tkeQ8
Endocrine University is a scientifically rigorous, clinically oriented 3-day educational program, designed to provide a forum for endocrinology fellows-in-training to enhance their endocrine curriculum, particularly in new technology, which has become essential to the practice of endocrinology. Over 250 participants will take part in clinical training and laboratory sessions, as well as the opportunity to meet experts in clinical endocrinology. The program takes a case-based approach to the diagnosis and management of endocrine-related disorders and is specifically designed to help prepare fellows for entering clinical practice.
Intended for medical residents and those in training, our Endocrine Education Cases Flashcards is an an educational pocket guide that covers vital topical areas in endocrinology through clinical cases that learners can reference in their studies or practice. Navigate the flashcards effortlessly between sections to get an in-depth review of the fundamentals of endocrinology!
These handheld flashcards provide concise, case-based guidance to build your confidence in identifying, treating, and managing endocrine diseases. In addition, this fully illustrated guide features a compact design, making it easier to reference recommendations on the major topic areas of endocrine care.
Authors are strongly encouraged to use appropriate reporting guidelines when preparing and submitting manuscripts, to maximize transparency and reproducibility. We particularly encourage the use of CONSORT for randomized clinical trials.
MRI Atlas of Pituitary Pathology is a concise review of the principles of MRI that provides a strong clinical teaching aid for endocrinologists, radiologists and neurosurgeons in training, as well as a reference guide for physicians.
The Atlas provides a visual case-based approach that reviews various pituitary pathologies. Numerous high-resolution images chronicle the most common to the rarest pituitary disorders. The book was developed as a guide for anyone involved in the multidisciplinary diagnosis of pituitary disease.
An important part of clinical endocrinology, dynamic testing plays a critical role in clinical decision-making and is an important element of billing and compliance with high quality standards. However, evidence-based national guidelines for these tests are scarce.
The classic point-of-care guide to the undifferentiated patient - enhanced with even more color photographs Part physical examination primer, part differential diagnosis tool, DeGowin's Diagnostic Examination takes readers a step beyond elementary physical diagnosis. DeGowin's covers all physical examination techniques and procedures, but this highly practical point-of-care guide goes further, focusing on the meaning of signs and symptoms. It also shows readers how to catalog clinical findings resulting from the physical examination-and order them into a differential diagnosis. This classic text is unrivaled in its comprehensive coverage of differential diagnosis, organized by signs, symptoms, and syndromes. This edition reflects the latest developments in the evidence-based physical examination The perfect bride text between physical exam textbooks and clinical medicine textbooks.
A concise guide to the selection and interpretation of more than 450 of the laboratory and microbiology tests most relevant to the general practice of medicine. This on-the-spot clinical companion also includes coverage of diagnostic imaging, electrocardiology, echocardiography, and the use of tests in differential diagnosis.
An easy-to-use guide to the diagnosis, treatment, and management of the full range of clinical conditions seen in primary care. New content includes coverage of genetics and precision medicine use in family medicine, telehealth in family medicine, CTE and sports injuries, Zika, the opioid epidemic, Hepatitis C, expansion of the HIV section, veteran's health and PTSD, and more. The leading resource for USMLE Step 3 review, board certification and maintenance or recertification, this text is essential for primary care trainees, practicing physicians, advanced practice nurses, and physician assistants.
Organized to reflect the course sequence in many pharmacology courses and in integrated curricula, the guide covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. This edition has been extensively updated to provide expanded coverage of transporters, pharmacogenomics, and new drugs
A unique case-based molecular approach to understanding pathology, Pathology: A Modern Case Study is a concise, focused text that emphasizes the molecular and cellular biology essential to understanding the concepts of disease causation. The book includes numerous case studies designed to highlight the role of the pathologist in the team that provides patient care. Pathology: A Modern Case Study examines the role of anatomic, clinical, and molecular pathologists in dedicated chapters and in descriptions of the pathology of specific organ systems.
Cases in AccessMedicine provide materials for short, targeted case-based learning. They vary slightly, but for each case you get a patient history and systems review, short answer questions, clinical pearls, and references. Cases are durable URL-enabled and can be linked to in coursework, e.g., LMS, lecture slides, etc. The results of the quizzes can be emailed and collected for a grade, e.g., student to instructor.
Required Federal Citations Use of Animals in Research: Recipients of PHS support for activities involving live, vertebrate animals must comply with PHS Policy on Humane Care and Use of Laboratory Animals ( ) as mandated by the Health Research Extension Act of 1985 ( ), and the USDA Animal Welfare Regulations ( ) as applicable. Human Subjects Protection: Federal regulations (45CFR46) require that applications and proposals involving human subjects must be evaluated with reference to the risks to the subjects, the adequacy of protection against these risks, the potential benefits of the research to the subjects and others, and the importance of the knowledge gained or to be gained ( ). Data and Safety Monitoring Plan: Data and safety monitoring is required for all types of clinical trials, including physiologic toxicity and dose-finding studies (phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative trials (Phase III). Monitoring should be commensurate with risk. The establishment of data and safety monitoring boards (DSMBs) is required for multi-site clinical trials involving interventions that entail potential risks to the participants (NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts, -files/not98-084.html). Sharing Research Data: Investigators submitting an NIH application seeking $500,000 or more in direct costs in any single year are expected to include a plan for data sharing or state why this is not possible ( _sharing). Investigators should seek guidance from their institutions, on issues related to institutional policies and local IRB rules, as well as local, State and Federal laws and regulations, including the Privacy Rule. Reviewers will consider the data sharing plan but will not factor the plan into the determination of the scientific merit or the priority score. Access to Research Data through the Freedom of Information Act: The Office of Management and Budget (OMB) Circular A-110 has been revised to provide access to research data through the Freedom of Information Act (FOIA) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. NIH has provided guidance at _guidance_dec1999.htm. Applicants may wish to place data collected under this funding opportunity in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures given the potential for wider use of data collected under this award. Sharing of Model Organisms: NIH is committed to support efforts that encourage sharing of important research resources including the sharing of model organisms for biomedical research (see _organism/index.htm). At the same time the NIH recognizes the rights of grantees and contractors to elect and retain title to subject inventions developed with Federal funding pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement _2003/index.htm). All investigators submitting an NIH application or contract proposal, beginning with the October 1, 2004 receipt date, are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding or state why such sharing is restricted or not possible. This will permit other researchers to benefit from the resources developed with public funding. The inclusion of a model organism sharing plan is not subject to a cost threshold in any year and is expected to be included in all applications where the development of model organisms is anticipated. Inclusion of Women And Minorities in Clinical Research: It is the policy of the NIH that women and members of minority groups and their sub-populations must be included in all NIH-supported clinical research projects unless a clear and compelling justification is provided indicating that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All investigators proposing clinical research should read the \"NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research ( -files/NOT-OD-02-001.html); a complete copy of the updated Guidelines is available at _min/guidelines_amended_10_2001.htm. The amended policy incorporates: the use of an NIH definition of clinical research; updated racial and ethnic categories in compliance with the new OMB standards; clarification of language governing NIH-defined Phase III clinical trials consistent with the new PHS Form 398; and updated roles and responsibilities of NIH staff and the extramural community. The policy continues to require for all NIH-defined Phase III clinical trials that: a) all applications or proposals and/or protocols must provide a description of plans to conduct analyses, as appropriate, to address differences by sex/gender and/or racial/ethnic groups, including subgroups if applicable; and b) investigators must report annual accrual and progress in conducting analyses, as appropriate, by sex/gender and/or racial/ethnic group differences. Inclusion of Children as Participants in Clinical Research: The NIH maintains a policy that children (i.e., individuals under the age of 21) must be included in all clinical research, conducted or supported by the NIH, unless there are scientific and ethical reasons not to include them. All investigators proposing research involving human subjects should read the \"NIH Policy and Guidelines\" on the inclusion of children as participants in research involving human subjects ( ). Required Education on the Protection of Human Subject Participants: NIH policy requires education on the protection of human subject participants for all investigators submitting NIH applications for research involving human subjects and individuals designated as key personnel. The policy is available at -files/NOT-OD-00-039.html. Human Embryonic Stem Cells (hESC): Criteria for federal funding of research on hESCs can be found at and at -files/NOT-OD-02-005.html. Only research using hESC lines that are registered in the NIH Human Embryonic Stem Cell Registry will be eligible for Federal funding ( ). It is the responsibility of the applicant to provide in the project description and elsewhere in the application as appropriate, the official NIH identifier(s) for the hESC line(s)to be used in the proposed research. Applications that do not provide this information will be returned without review. NIH Public Access Policy: NIH-funded investigators are requested to submit to the NIH manuscript submission (NIHMS) system ( ) at PubMed Central (PMC) an electronic version of the author's final manuscript upon acceptance for publication, resulting from research supported in whole or in part with direct costs from NIH. The author's final manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process. NIH is requesting that authors submit manuscripts resulting from 1) currently funded NIH research projects or 2) previously supported NIH research projects if they are accepted for publication on or after May 2, 2005. The NIH Public Access Policy applies to all research grant and career development award mechanisms, cooperative agreements, contracts, Institutional and Individual Ruth L. Kirschstein National Research Service Awards, as well as NIH intramural research studies. The Policy applies to peer-reviewed, original research publications that have been supported in whole or in part with direct costs from NIH, but it does not apply to book chapters, editorials, reviews, or conference proceedings. Publications resulting from non-NIH-supported research projects should not be submitted. For more information about the Policy or the submission process please visit the NIH Public Access Policy Web site at and view the Policy or other Resources and Tools including the Authors' Manual ( _manual.htm). Standards for Privacy of Individually Identifiable Health Information: The Department of Health and Human Services (DHHS) issued final modification to the \"Standards for Privacy of Individually Identifiable Health Information\", the \"Privacy Rule\", on August 14, 2002 . The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the DHHS Office for Civil Rights (OCR). Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website ( ) provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on \"Am I a covered entity\" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at -files/NOT-OD-03-025.html. URLs in NIH Grant Applications or Appendices: All applications and proposals for NIH funding must be self-contained within specified page limitations. Unless otherwise specified in an NIH solicitation, Internet addresses (URLs) should not be used to provide information necessary to the review because reviewers are under no obligation to view the Internet sites. Furthermore, we caution reviewers that their anonymity may be compromised when they directly access an Internet site. Healthy People 2010: The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of \"Healthy People 2010,\" a PHS-led national activity for setting priority areas. This PA is related to one or more of the priority areas. Potential applicants may obtain a copy of \"Healthy People 2010\" at Authority and Regulations: This program is described in the Catalog of Federal Domestic Assistance at and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The NIH Grants Policy Statement can be found at The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. Loan Repayment Programs: NIH encourages applications for educational loan repayment from qualified health professionals who have made a commitment to pursue a research career involving clinical, pediatric, contraception, infertility, and health disparities related areas. The LRP is an important component of NIH's efforts to recruit and retain the next generation of researchers by providing the means for developing a research career unfettered by the burden of student loan debt. Note that an NIH grant is not required for eligibility and concurrent career award and LRP applications are encouraged. The periods of career award and LRP award may overlap providing the LRP recipient with the required commitment of time and effort, as LRP awardees must commit at least 50% of their time (at least 20 hours per week based on a 40 hour week) for two years to the research. For further information, please see: TOC for this AnnouncementNIH Funding Opportunities and Notices Office of ExtramuralResearch (OER) National Institutes of Health (NIH)9000 Rockville PikeBethesda, Maryland 20892 Department of Healthand Human Services (HHS) Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. 59ce067264